6533b86ffe1ef96bd12cdcd6
RESEARCH PRODUCT
Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer
Baris TurkbeyBradford J. WoodJonathan BloomPeter A. PintoPeter L. ChoykeSherif MehralivandSherif MehralivandMarcin CzarnieckiVladimir ValeraSamuel GoldVikram SabarwalJoseph A. BaioccoKareem RaynGraham R. HaleMaria J. Merinosubject
Image-Guided BiopsyMalePathologymedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyMagnetic Resonance Imaging InterventionalRisk AssessmentArticle03 medical and health sciencesProstate cancer0302 clinical medicinePredictive Value of TestsProstatePreoperative CareImage Processing Computer-AssistedmedicineHumansProspective StudiesUltrasonography InterventionalMultiparametric Magnetic Resonance ImagingAgedRetrospective Studiesbusiness.industryProstatectomyProstateProstatic NeoplasmsMiddle AgedNomogrammedicine.diseaseMagnetic Resonance ImagingPI-RADSProstate-specific antigenNomogramsmedicine.anatomical_structure030220 oncology & carcinogenesisFeasibility StudiesBiopsy Large-Core NeedleNeoplasm GradingbusinessImage-Guided Biopsyhuman activitiesdescription
PURPOSE: We examined the additional value of preoperative prostate multiparametric magnetic resonance imaging and transrectal ultrasound/multiparametric magnetic resonance imaging fusion guided targeted biopsy when performed in combination with clinical nomograms to predict adverse pathology at radical prostatectomy. MATERIALS AND METHODS: We identified all patients who underwent 3 Tesla multiparametric magnetic resonance imaging prior to fusion biopsy and radical prostatectomy. The Partin and the MSKCC (Memorial Sloan Kettering Cancer Center) preradical prostatectomy nomograms were applied to estimate the probability of organ confined disease, extraprostatic extension, seminal vesicle invasion and lymph node involvement using transrectal ultrasound guided systematic biopsy and transrectal ultrasound/multiparametric magnetic resonance imaging fusion guided targeted biopsy Gleason scores. With radical prostatectomy pathology as the gold standard we developed multivariable logistic regression models based on these nomograms before and after adding multiparametric magnetic resonance imaging to assess any additional predictive ability. RESULTS: A total of 532 patients were included in study. When multiparametric magnetic resonance imaging findings were added to the systematic biopsy based MSKCC nomogram, the AUC increased by 0.10 for organ confined disease (p <0.001), 0.10 for extraprostatic extension (p = 0.003), 0.09 for seminal vesicle invasion (p = 0.011) and 0.06 for lymph node involvement (p = 0.120). Using Gleason scores derived from targeted biopsy compared to systematic biopsy provided an additional predictive value of organ confined disease (Δ AUC 0.07, p = 0.003) and extraprostatic extension (Δ AUC 0.07, p = 0.048) at radical prostatectomy with the MSKCC nomogram. Similar results were obtained using the Partin nomogram. CONCLUSIONS: Magnetic resonance imaging alone or in addition to standard clinical nomograms provides significant additional predictive ability of adverse pathology at the time of radical prostatectomy. This information can be greatly beneficial to urologists for preoperative planning and for counseling patients regarding the risks of future therapy.
year | journal | country | edition | language |
---|---|---|---|---|
2018-11-01 |